The contribution of reduced functioning mass to chronic kidney allograft dysfunction in rats.
Chronic renal allograft dysfunction may become manifest months or years after transplantation by progressive functional deterioration associated with morphological changes that include vascular obliteration, glomerular sclerosis, tubular atrophy, and interstitial fibrosis. Two hypotheses have evolved to explain the etiology of this process, usually described as "chronic rejection:" first, that it is primarily an antigen-dependent phenomenon influenced by continuing host alloresponsiveness; second, that nonimmunological, alloantigen-independent factors contribute to the progressive changes. Using an established model of chronic rejection of kidney transplants in rats in which the lesions progress relentlessly over time, we have determined the long-term effects of superimposing renal mass reduction on the indices of progressive allograft injury. Increasing proteinuria, a reproducible index of kidney graft dysfunction, developed after 12 weeks in all recipients of intact allografts, but was accelerated in kidneys with reduced mass, regardless of whether the organ was allogeneic or isogeneic. The coincident infiltration of macrophages and expression of cytokines and growth factors were associated with the development of glomerular sclerosis and interstitial fibrosis; such functional and morphological alterations occurred in an accelerated manner in all reduced-mass kidney allografts and isografts. Conversely, intact allografts in recipients also bearing a retained native kidney never manifested any chronic changes throughout the entire follow-up period. These findings emphasize the role of alloantigen-independent factors, particularly reduced renal mass, in the multi-factorial etiology of "chronic rejection" of kidney transplants.
Heemann
U W
UW
Surgical Research Laboratory, Harvard Medical School, Boston, Massachusetts 02115.
Azuma
H
H
Tullius
S G
SG
Mackenzie
H
H
Brenner
B M
BM
Tilney
N L
NL
D000818:Animals; D015703:Antigens, CD / Q000032:analysis; D001284:Atrophy / Q000473:pathology; D018956:CD5 Antigens; D005355:Fibrosis / Q000473:pathology; D006084:Graft Rejection / Q000209:etiology* / Q000276:immunology / Q000503:physiopathology; D006085:Graft Survival / Q000502:physiology; D007150:Immunohistochemistry; D007668:Kidney / Q000276:immunology / Q000473:pathology / Q000503:physiopathology*; D016030:Kidney Transplantation / Q000276:immunology / Q000473:pathology*; D008297:Male; D051381:Rats; D011916:Rats, Inbred F344; D011917:Rats, Inbred Lew; D013601:T-Lymphocytes / Q000276:immunology; D013997:Time Factors; D014184:Transplantation, Homologous
D015703:Antigens, CD; D018956:CD5 Antigens